BFEC
TWST icon

Benjamin F. Edwards & Company’s Twist Bioscience TWST Stock Holding History

Benjamin F. Edwards & Company’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$846K Buy
17,166
+16,858
+5,473% +$687K 0.01% 572
2024
Q1 		$11K Buy
+308
New +$11.1K ﹤0.01% 1686

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Benjamin F. Edwards & Company's TWST Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Twist Bioscience (TWST) stake by 5,473% in Q2 2024, buying an estimated $687K and bringing the position to 17,166 shares worth $846K. The position accounts for 0.01% of the portfolio, ranked #572.

Benjamin F. Edwards & Company first reported a position in TWST in Q1 2024 and has held it in 2 quarters since. 263 funds tracked by Wall St. Rank hold TWST as of Q2 2024.

  • Benjamin F. Edwards & Company held 17,166 shares of Twist Bioscience worth $846K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 16,858 Twist Bioscience shares in Q2 2024, an estimated $687K.
  • Twist Bioscience made up 0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #572 holding.
  • Benjamin F. Edwards & Company first reported a position in Twist Bioscience in Q1 2024 and has held it in 2 quarters since.
  • 263 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.